Latest Distributions News

PT ANTAM (ASX:ATM) posted a 12% rise in gold production in 2Q26 and advanced key downstream projects including EV battery ecosystem development, while securing multiple ESG awards.

Strike Resources is progressing the sale of a 28.52% indirect stake in its high-grade Apurímac Iron Ore Project for A$5.5 million, while advancing exploration programs and preparing for potential small-scale mining under Peru’s artisanal regime. The company also holds a 27.7% interest in LE Minerals, which is spinning out its Graphite Projects via an IPO.

Venus Metals Corporation (ASX:VMC) has fortified its balance sheet with a $47 million sale of its Youanmi Gold Project royalty, rebuffed a hostile takeover, and set in motion significant shareholder returns including a $35 million cash dividend.

Clarity Pharmaceuticals bolsters its commercial readiness with a $178.3 million cash reserve and a key US manufacturing agreement, while clinical trials for its prostate cancer imaging and therapeutic agents progress with promising data.

IMEXHS Limited posted a 21% revenue increase in Q2 FY26, driven by a landmark public tender in Mexico deploying its AI-powered Aquila+ radiology platform. The company’s proprietary AI agents are now operational in live environments, supporting its strategy to own the full radiology workflow.

Acrux Limited’s FY26 receipts soared 960% to $5 million, fuelled by licensing milestones and growing generic sales, while FDA guidance clears the way for pivotal Phase III trials of its Female Testosterone therapy.

Pacgold secures $13 million via placement to accelerate production and exploration at White Dam following a high-grade gold-copper discovery.

Pure One Corporation has made strides in zero-emission commercial vehicles with new battery-swap and electric models arriving in Australia, backed by a strengthened balance sheet from a $3.5 million tranche of Turquoise Group sale proceeds.

Argosy Minerals has made significant strides in its 12ktpa Rincon Lithium Project, delivering encouraging process testwork results and securing critical 40MW energy infrastructure, while engaging strategic partners for funding.

ClearVue Technologies bolstered its balance sheet with a A$6 million capital raise while landing high-profile projects including Canva’s Sydney HQ and its first European contract in Cyprus. The company also advanced international expansion and achieved key certifications confirming product durability and safety.

Tissue Repair advances its US Phase III chronic wound trial with 100 patients randomised and targets October FDA 510(k) submission. The company reports a robust cash position bolstered by R&D refunds and has cut manufacturing scale-up costs.

Famien Resources has confirmed multiple high-grade gold intercepts across several prospects in Côte d’Ivoire, progressing its exploration with key drilling results and regional sampling programs.